In this study, we developed a novel hiPSC-CM model of ARVC derived from a patient with a likely pathogenic variant in DSG2. We characterized a variety of functional and molecular features that could help link the cellular behavior with clinical manifestation of ARVC. This evidence concerns the gene DSG2 and Arrhythmogenic right ventricular dysplasia.